Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chamberlain

Showing results (371-380 of 396) with videos related to

Pageof 40
Sort By:
Circulation|June 23, 2022
Effects of Coronary Artery Disease-Associated Variants on Vascular Smooth Muscle CellsCharles U Solomon, David G McVey, Catherine Andreadi, et al.
Journal of Neuro-Oncology|December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter studyManmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.
Neuro-Oncology|April 24, 2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomasNathalie L Albert, Michael Weller, Bogdana Suchorska, et al.
Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastomaWolfgang Wick, Vinay K Puduvalli, Marc C Chamberlain, et al.
Nature Biomedical Engineering|September 19, 2025
Spatial profiling of gene editing by in situ sequencing in mice and macaquesSharan Janjuha, Tatjana Haenggi, Thomas C Chamberlain, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of actionKaren K Biron, Robert J Harvey, Stanley C Chamberlain, et al.
Journal of Neuro-Oncology|March 5, 2013
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancerE Le Rhun, S Taillibert, F Zairi, et al.
Neuro-Oncology|March 5, 2008
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignanciesMorris D Groves, Michael J Glantz, Marc C Chamberlain, et al.
Neuro-Oncology|May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working GroupNils D Arvold, Terri S Armstrong, Katherine E Warren, et al.
Pageof 40

Showing results (371-380 of 396) with videos related to

Sort By:
Pageof 40
Circulation|June 23, 2022
Effects of Coronary Artery Disease-Associated Variants on Vascular Smooth Muscle CellsCharles U Solomon, David G McVey, Catherine Andreadi, et al.
Journal of Neuro-Oncology|December 24, 2014
Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter studyManmeet S Ahluwalia, Hao Xie, Saurabh Dahiya, et al.
Neuro-Oncology|April 24, 2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomasNathalie L Albert, Michael Weller, Bogdana Suchorska, et al.
Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastomaWolfgang Wick, Vinay K Puduvalli, Marc C Chamberlain, et al.
Nature Biomedical Engineering|September 19, 2025
Spatial profiling of gene editing by in situ sequencing in mice and macaquesSharan Janjuha, Tatjana Haenggi, Thomas C Chamberlain, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of actionKaren K Biron, Robert J Harvey, Stanley C Chamberlain, et al.
Journal of Neuro-Oncology|March 5, 2013
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancerE Le Rhun, S Taillibert, F Zairi, et al.
Neuro-Oncology|March 5, 2008
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignanciesMorris D Groves, Michael J Glantz, Marc C Chamberlain, et al.
Neuro-Oncology|May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working GroupNils D Arvold, Terri S Armstrong, Katherine E Warren, et al.
Pageof 40